Abstract
National Resilience, a venture-backed pharmaceutical services company formed last year, will acquire Ology Bioservices, a maker of active ingredients for biologic drugs, in Alachua, Florida. Resilience, which targets the development of manufacturing processes for advanced drugs, previously acquired Therapure Biopharma in Ontario and a former Genzyme plant in Boston. It also recently subleased an Orchard Therapeutics gene therapy facility in Fremont, California.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
